Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2026-07-23 @ 12:55 AM
Study NCT ID:
NCT00248404
Status:
COMPLETED
Last Update Posted:
2022-05-16
First Post:
2005-11-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)
Sponsor:
Kiadis Pharma
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Tumors | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | colorectal cancer | View |
| None | ovarian cancer | View |
| None | lung cancer | View |
| None | breast cancer | View |
| None | small bowel cancer | View |
| None | Advanced, recurrent, or metastatic solid tumors of any type | View |
| None | TS overexpression confirmed by fresh biopsy (RTPCR) | View |
| None | Suitable for experimental monotherapy | View |